California 2023-2024 Regular Session

California Assembly Bill AB1976

Introduced
1/30/24  
Refer
2/12/24  
Refer
2/12/24  
Report Pass
4/4/24  
Report Pass
4/4/24  
Refer
4/4/24  
Refer
4/4/24  
Refer
4/17/24  
Refer
4/17/24  
Report Pass
5/20/24  
Report Pass
5/20/24  
Engrossed
5/22/24  
Refer
5/23/24  
Refer
5/23/24  
Refer
6/5/24  
Report Pass
6/12/24  
Report Pass
6/12/24  
Refer
6/13/24  
Refer
6/13/24  
Refer
6/24/24  
Refer
6/24/24  
Report Pass
8/15/24  
Report Pass
8/15/24  
Enrolled
8/28/24  
Enrolled
8/28/24  
Chaptered
9/27/24  
Chaptered
9/27/24  
Passed
9/27/24  

Caption

Occupational safety and health standards: first aid materials: opioid antagonists.

Impact

If enacted, AB 1976 will reinforce safety protocols related to opioid overdoses in workplace settings across California. It will add a significant layer of protection for individuals potentially at risk of overdosing, particularly in industries where opioid usage may be prevalent. Furthermore, it emphasizes the legal protection for those who administer naloxone to someone experiencing an overdose, aiming to promote a culture of emergency preparedness within workplaces. Under current laws, those administering naloxone in good faith are not liable for civil damages, a provision which the bill seeks to clarify and reinforce.

Summary

Assembly Bill No. 1976, introduced by Assemblymember Haney, seeks to enhance workplace safety by mandating that employers include naloxone hydrochloride or another FDA-approved opioid antagonist in first aid materials available at their workplaces. This aligns with existing labor laws that empower the Division of Occupational Safety and Health to set and enforce safety standards in California. The bill specifically requires a rulemaking proposal to be drafted by the division by December 1, 2027, which will detail these regulations and provide formal guidance for employers regarding proper storage and use of these life-saving medications.

Sentiment

The sentiment surrounding AB 1976 appears to be largely supportive among public health advocates and safety organizations, who view the bill as a proactive measure to save lives in the context of the opioid crisis. There is a recognition of the importance of readily available resources to mitigate overdose fatalities. However, there may be concerns from certain business groups regarding the implications of additional requirements on workplace safety protocols and associated costs, though these concerns are not extensively documented in the discussions surrounding the bill.

Contention

While the bill is generally supported, some stakeholders express apprehension over the potential burden it may impose on employers, particularly small businesses that might find additional safety training and materials financially challenging. The bill also raises questions about the effective implementation of these guidelines, particularly in ensuring that all employees are adequately trained to respond in overdose situations. Nevertheless, the overarching goal remains focused on increasing safety measures and reducing opioid-related deaths in the workplace.

Companion Bills

No companion bills found.

Similar Bills

CA SB472

Pupil health: opioid overdose reversal medication.

CA AB915

Pupil health: drug education: opioid overdose training program.

CA AB19

Pupil health: opioid antagonists.

CA AB3271

Pupil health: opioid antagonists.

CA AB1915

Pupil health: drug education: opioid overdose training program.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.